Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun;22(6):805-10.
doi: 10.1007/s11606-007-0193-5. Epub 2007 Apr 5.

Strategies for coping in a complex world: adherence behavior among older adults with chronic illness

Affiliations

Strategies for coping in a complex world: adherence behavior among older adults with chronic illness

Rachel A Elliott et al. J Gen Intern Med. 2007 Jun.

Abstract

Background: Increasing numbers of medicines increase nonadherence. Little is known about how older adults manage multiple medicines for multiple illnesses.

Objectives: To explore how older adults with multiple illnesses make choices about medicines.

Design: Semistructured interviews with older adults taking several medications. Accounts of respondents' medicine-taking behavior were collected.

Participants: Twenty community-dwelling seniors with health insurance, in Eastern Massachusetts, aged 67-90, (4-12 medicines, 3-9 comorbidities).

Approach: Qualitative analysis using constant comparison to explain real choices made about medicines in the past ("historical") and hypothetical ("future") choices.

Results: Respondents reported both past ("historical") choices and hypothetical ("future") choices between medicines. Although people discussed effectiveness and future risk of the disease when prompted to prioritize their medicines (future choices), key factors leading to nonadherence (historical choices) were costs and side effects. Specific choices were generally dominated by 1 factor, and respondents rarely reported making explicit trade-offs between different factors. Factors affecting 1 choice were not necessarily the same as those affecting another choice in the same person. There was no evidence of "adherent" personalities.

Conclusion: Prescribing a new medicine, a change in provider or copayment can provoke new choices about both new and existing medications in older adults with multiple morbidities.

PubMed Disclaimer

Similar articles

Cited by

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.mlr.0000114908.90348.f9', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.mlr.0000114908.90348.f9'}, {'type': 'PubMed', 'value': '15076819', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15076819/'}]}
    2. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research.[see comment]. Med Care 2004;42:200–9, Mar. - PubMed
    1. World Health Organisation. Adherence to long-term therapies. Evidence for action. http://www.who.int/chronic_conditions/adherencereport/en/ 2003 [cited 2005 May 7];
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '8657028', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8657028/'}]}
    2. Dartnell JGA, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust. 1996;164:659–62. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.263.12.1653', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.263.12.1653'}, {'type': 'PubMed', 'value': '1968518', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1968518/'}]}
    2. Psaty BM, Koepsell TD, Wagner EH, lo Gerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of B-blockers. J Am Med Assoc. 1990;263(12):1653–7. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '7481573', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7481573/'}]}
    2. Weiden PJ, Olfson M. Cost of relapse in schizophrenia. Schizophr Bull. 1995;21(3):419–29. - PubMed

Publication types